• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Daniel W. Cramer, MD, ScD

Publications

  • Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, Wang C, Tyrer J, Song H, deFazio A, Johnatty SE, Doherty JA, Phelan CM, Sellers TA, Ramirez SM, Vitonis AF, Terry KL, Van Den Berg D, Pike MC, Wu AH, Berchuck A, Gentry-Maharaj A, Ramus SJ, Diergaarde B, Shen H, Jensen A, Menkiszak J, Cybulski C, Lubiłski J, Ziogas A, Rothstein JH, McGuire V, Sieh W, Lester J, Walsh C, Vergote I, Lambrechts S, Despierre E, Garcia-Closas M, Yang H, Brinton LA, Spiewankiewicz B, Rzepecka IK, Dansonka-Mieszkowska A, Seibold P, Rudolph A, Paddock LE, Orlow I, Lundvall L, Olson SH, Hogdall CK, Schwaab I, du Bois A, Harter P, Flanagan JM, Brown R, Paul J, Ekici AB, Beckmann MW, Hein A, Eccles D, Lurie G, Hays LE, Bean YT, Pejovic T, Goodman MT, Campbell I, Fasching PA, Konecny G, Kaye SB, Heitz F, Hogdall E, Bandera EV, Chang-Claude J, Kupryjanczyk J, Wentzensen N, Lambrechts D, Karlan BY, Whittemore AS, Culver HA, Gronwald J, Levine DA, Kjaer SK, Menon U, Schildkraut JM, Pearce CL, Cramer DW, Rossing MA, Chenevix-Trench G, , , Pharoah PD, Gayther SA, Ness RB, Odunsi K, Sucheston LE, Knutson KL, Goode EL.Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.Cancer Immunol Res. 2014 Apr;2(4):332-40.
    24764580
  • Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, , , Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, Lambrechts S, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Friel G, Moysich KB, Odunsi K, Sucheston-Campbell L, Lurie G, Goodman MT, Carney ME, Thompson PJ, Runnebaum IB, Dürst M, Hillemanns P, Dörk T, Antonenkova N, Bogdanova N, Leminen A, Nevanlinna H, Pelttari LM, Butzow R, Bunker CH, Modugno F, Edwards RP, Ness RB, du Bois A, Heitz F, Schwaab I, Harter P, Karlan BY, Walsh C, Lester J, Jensen A, Kjær SK, Høgdall CK, Høgdall E, Lundvall L, Sellers TA, Fridley BL, Goode EL, Cunningham JM, Vierkant RA, Giles GG, Baglietto L, Severi G, Southey MC, Liang D, Wu X, Lu K, Hildebrandt MA, Levine DA, Bisogna M, Schildkraut JM, Iversen ES, Weber RP, Berchuck A, Cramer DW, Terry KL, Poole EM, Tworoger SS, Bandera EV, Chandran U, Orlow I, Olson SH, Wik E, Salvesen HB, Bjorge L, Halle MK, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean YT, Cybulski C, Gronwald J, Lubinski J, Wentzensen N, Brinton LA, Lissowska J, Garcia-Closas M, Dicks E, Dennis J, Easton DF, Song H, Tyrer JP, Pharoah PD, Eccles D, Campbell IG, Whittemore AS, McGuire V, Sieh W, Rothstein JH, Flanagan JM, Paul J, Brown R, Phelan CM, Risch HA, McLaughlin JR, Narod SA, Ziogas A, Anton-Culver H, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Wu AH, Pearce CL, Pike MC, Dansonka-Mieszkowska A, Rzepecka IK, Szafron LM, Kupryjanczyk J, Cook LS, Le ND, Brooks-Wilson A, .Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Hum Genet. 2014 May;133(5):481-97.
    24190013
  • Williams KA, Labidi-Galy SI, Terry KL, Vitonis AF, Welch WR, Goodman A, Cramer DW.Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.Gynecol Oncol. 2014 Mar;132(3):542-50.
    24462730
  • Williams KA, Terry KL, Tworoger SS, Vitonis AF, Titus LJ, Cramer DW.Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival.PLoS ONE. 2014;9(2):e88334.
    24551091
  • Elias KM, Labidi-Galy SI, Vitonis AF, Hornick JL, Doyle LA, Hirsch MS, Cramer DW, Drapkin R.Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.Gynecol Oncol. 2014 Feb;132(2):328-33.
    24342438
  • Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ, , Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjær SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N, .Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.Journal of the National Cancer Institute. 2014 Feb;106(2):djt431.
    24503200
  • Cramer DW, Williams K, Vitonis AF, Yamamoto HS, Stuebe A, Welch WR, Titus L, Fichorova RN.Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk.Cancer Causes Control. 2013 Nov;24(11):1911-23.
    23925696
  • Johnatty SE, Beesley J, Gao B, Chen X, Lu Y, Law MH, Henderson MJ, Russell AJ, Hedditch EL, Emmanuel C, Fereday S, Webb PM, , Goode EL, Vierkant RA, Fridley BL, Cunningham JM, Fasching PA, Beckmann MW, Ekici AB, Hogdall E, Kjaer SK, Jensen A, Hogdall C, Brown R, Paul J, Lambrechts S, Despierre E, Vergote I, Lester J, Karlan BY, Heitz F, du Bois A, Harter P, Schwaab I, Bean Y, Pejovic T, Levine DA, Goodman MT, Camey ME, Thompson PJ, Lurie G, Shildkraut J, Berchuck A, Terry KL, Cramer DW, Norris MD, Haber M, MacGregor S, deFazio A, Chenevix-Trench G.ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.Gynecol Oncol. 2013 Oct;131(1):8-14.
    23917080
  • Cramer DW, Finn OJ.Incidence rate of breast cancer in young women.JAMA. 2013 Jun 19;309(23):2434-5.
    23780450
  • Rice MS, Murphy MA, Vitonis AF, Cramer DW, Titus LJ, Tworoger SS, Terry KL.Tubal ligation, hysterectomy, and epithelial ovarian cancer in the New England case-control study.Int J Cancer. 2013 May 3.
    23650079
  • Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, , , Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, Goodman MT, Ness RB, Modugno F, Edwards RP, Bunker CH, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Cramer DW, Terry KL, Vitonis AF, Bandera EV, Olson SH, King M, Chandran U, Kiemeney LA, Massuger LF, van Altena AM, Vermeulen SH, Brinton L, Wentzensen N, Lissowska J, Yang HP, Moysich KB, Odunsi K, Kasza K, Odunsi-Akanji O, Song H, Pharaoh P, Shah M, Whittemore AS, McGuire V, Sieh W, Sutphen R, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Pike MC, Risch HA, Jensen A, .Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.Cancer Causes Control. 2013 May;24(5):989-1004.
    23456270
  • Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ, , , Goodman MT, Lurie G, Chang-Claude J, Rudolph A, Kjær SK, Jensen A, Høgdall E, Bandera EV, Olson SH, King MG, Rodriguez-Rodriguez L, Kiemeney LA, Marees T, Massuger LF, van Altena AM, Ness RB, Cramer DW, Pike MC, Pearce CL, Berchuck A, Schildkraut JM, Whittemore AS, .Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.Int J Epidemiol. 2013 Apr;42(2):579-589.
    23569193
  • Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, Baynes C, Bolla MK, Wang Q, Dennis J, McGuffog L, Barrowdale D, Lee A, Healey S, Lush M, Tessier DC, Vincent D, Bacot F, , , , , , , , , Vergote I, Lambrechts S, Despierre E, Risch HA, González-Neira A, Rossing MA, Pita G, Doherty JA, Alvarez N, Larson MC, Fridley BL, Schoof N, Chang-Claude J, Cicek MS, Peto J, Kalli KR, Broeks A, Armasu SM, Schmidt MK, Braaf LM, Winterhoff B, Nevanlinna H, Konecny GE, Lambrechts D, Rogmann L, Guénel P, Teoman A, Milne RL, Garcia JJ, Cox A, Shridhar V, Burwinkel B, Marme F, Hein R, Sawyer EJ, Haiman CA, Wang-Gohrke S, Andrulis IL, Moysich KB, Hopper JL, Odunsi K, Lindblom A, Giles GG, Brenner H, Simard J, Lurie G, Fasching PA, Carney ME, Radice P, Wilkens LR, Swerdlow A, Goodman MT, Brauch H, Garcia-Closas M, Hillemanns P, Winqvist R, Dürst M, Devilee P, Runnebaum I, Jakubowska A, Lubinski J, Mannermaa A, Butzow R, Bogdanova NV, Dörk T, Pelttari LM, Zheng W, Leminen A, Anton-Culver H, Bunker CH, Kristensen V, Ness RB, Muir K, Edwards R, Meindl A, Heitz F, Matsuo K, du Bois A, Wu AH, Harter P, Teo SH, Schwaab I, Shu XO, Blot W, Hosono S, Kang D, Nakanishi T, Hartman M, Yatabe Y, Hamann U, Karlan BY, Sangrajrang S, Kjaer SK, Gaborieau V, Jensen A, Eccles D, Høgdall E, Shen CY, Brown J, Woo YL, Shah M, Azmi MA, Luben R, Omar SZ, Czene K, Vierkant RA, Nordestgaard BG, Flyger H, Vachon C, Olson JE, Wang X, Levine DA, Rudolph A, Weber RP, Flesch-Janys D, Iversen E, Nickels S, Schildkraut JM, Silva Idos S, Cramer DW, Gibson L, Terry KL, Fletcher O, Vitonis AF, van der Schoot CE, Poole EM, Hogervorst FB, Tworoger SS, Liu J, Bandera EV, Li J, Olson SH, Humphreys K, Orlow I, Blomqvist C, Rodriguez-Rodriguez L, Aittomäki K, Salvesen HB, Muranen TA, Wik E, Brouwers B, Krakstad C, Wauters E, Halle MK, Wildiers H, Kiemeney LA, Mulot C, Aben KK, Laurent-Puig P, Altena AM, Truong T, Massuger LF, Benitez J, Pejovic T, Perez JI, Hoatlin M, Zamora MP, Cook LS, Balasubramanian SP, Kelemen LE, Schneeweiss A, Le ND, Sohn C, Brooks-Wilson A, Tomlinson I, Kerin MJ, Miller N, Cybulski C, Henderson BE, Menkiszak J, Schumacher F, Wentzensen N, Le Marchand L, Yang HP, Mulligan AM, Glendon G, Engelholm SA, Knight JA, Høgdall CK, Apicella C, Gore M, Tsimiklis H, Song H, Southey MC, Jager A, den Ouweland AM, Brown R, Martens JW, Flanagan JM, Kriege M, Paul J, Margolin S, Siddiqui N, Severi G, Whittemore AS, Baglietto L, McGuire V, Stegmaier C, Sieh W, Müller H, Arndt V, Labrèche F, Gao YT, Goldberg MS, Yang G, Dumont M, McLaughlin JR, Hartmann A, Ekici AB, Beckmann MW, Phelan CM, Lux MP, Permuth-Wey J, Peissel B, Sellers TA, Ficarazzi F, Barile M, Ziogas A, Ashworth A, Gentry-Maharaj A, Jones M, Ramus SJ, Orr N, Menon U, Pearce CL, Brüning T, Pike MC, Ko YD, Lissowska J, Figueroa J, Kupryjanczyk J, Chanock SJ, Dansonka-Mieszkowska A, Jukkola-Vuorinen A, Rzepecka IK, Pylkäs K, Bidzinski M, Kauppila S, Hollestelle A, Seynaeve C, Tollenaar RA, Durda K, Jaworska K, Hartikainen JM, Kosma VM, Kataja V, Antonenkova NN, Long J, Shrubsole M, Deming-Halverson S, Lophatananon A, Siriwanarangsan P, Stewart-Brown S, Ditsch N, Lichtner P, Schmutzler RK, Ito H, Iwata H, Tajima K, Tseng CC, Stram DO, van den Berg D, Yip CH, Ikram MK, Teh YC, Cai H, Lu W, Signorello LB, Cai Q, Noh DY, Yoo KY, Miao H, Iau PT, Teo YY, McKay J, Shapiro C, Ademuyiwa F, Fountzilas G, Hsiung CN, Yu JC, Hou MF, Healey CS, Luccarini C, Peock S, Stoppa-Lyonnet D, Peterlongo P, Rebbeck TR, Piedmonte M, Singer CF, Friedman E, Thomassen M, Offit K, Hansen TV, Neuhausen SL, Szabo CI, Blanco I, Garber J, Narod SA, Weitzel JN, Montagna M, Olah E, Godwin AK, Yannoukakos D, Goldgar DE, Caldes T, Imyanitov EN, Tihomirova L, Arun BK, Campbell I, Mensenkamp AR, van Asperen CJ, van Roozendaal KE, Meijers-Heijboer H, Collée JM, Oosterwijk JC, Hooning MJ, Rookus MA, van der Luijt RB, Os TA, Evans DG, Frost D, Fineberg E, Barwell J, Walker L, Kennedy MJ, Platte R, Davidson R, Ellis SD, Cole T, Bressac-de Paillerets B, Buecher B, Damiola F, Faivre L, Frenay M, Sinilnikova OM, Caron O, Giraud S, Mazoyer S, Bonadona V, Caux-Moncoutier V, Toloczko-Grabarek A, Gronwald J, Byrski T, Spurdle AB, Bonanni B, Zaffaroni D, Giannini G, Bernard L, Dolcetti R, Manoukian S, Arnold N, Engel C, Deissler H, Rhiem K, Niederacher D, Plendl H, Sutter C, Wappenschmidt B, Borg A, Melin B, Rantala J, Soller M, Nathanson KL, Domchek SM, Rodriguez GC, Salani R, Kaulich DG, Tea MK, Paluch SS, Laitman Y, Skytte AB, Kruse TA, Jensen UB, Robson M, Gerdes AM, Ejlertsen B, Foretova L, Savage SA, Lester J, Soucy P, Kuchenbaecker KB, Olswold C, Cunningham JM, Slager S, Pankratz VS, Dicks E, Lakhani SR, Couch FJ, Hall P, Monteiro AN, Gayther SA, Pharoah PD, Reddel RR, Goode EL, Greene MH, Easton DF, Berchuck A, Antoniou AC, Chenevix-Trench G, Dunning AM.Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nat Genet. 2013 Apr;45(4):371-84.
    23535731
  • Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, , Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Ling Woo Y, Winterhoff B, Wik E, Whittemore AS, Wentzensen N, Palmieri Weber R, Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry KL, Teo SH, Templeman C, Stram DO, Southey MC, Sieh W, Siddiqui N, Shvetsov YB, Shu XO, Shridhar V, Wang-Gohrke S, Severi G, Schwaab I, Salvesen HB, Rzepecka IK, Runnebaum IB, Anne Rossing M, Rodriguez-Rodriguez L, Risch HA, Renner SP, Poole EM, Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Zawiah Omar S, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, Nakanishi T, Moysich KB, Monteiro AN, Moes-Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Mat Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubiński J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts D, Kupryjanczyk J, Krakstad C, Konecny GE, Krüger Kjaer S, Kiemeney LA, Kelemen LE, Keeney GL, Karlan BY, Karevan R, Kalli KR, Kajiyama H, Ji BT, Jensen A, Jakubowska A, Iversen E, Hosono S, Høgdall CK, Høgdall E, Hoatlin M, Hillemanns P, Heitz F, Hein R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Giles GG, Gentry-Maharaj A, Garcia-Closas M, Flanagan JM, Fasching PA, Ekici AB, Edwards R, Eccles D, Easton DF, Dürst M, du Bois A, Dörk T, Doherty JA, Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova N, Block MS, Benjamin E, Beesley J, Beckmann MW, Bandera EV, Baglietto L, Bacot F, Armasu SM, Antonenkova N, Anton-Culver H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA, , , Schildkraut JM, Sellers TA, Huntsman D, Berchuck A, Chenevix-Trench G, Gayther SA, Pharoah PD, Laird PW, Goode EL, Leigh Pearce C.Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.Nat Commun. 2013 Mar 27;4:1628.
    23535649
  • Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Ann Chen Y, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, Aben KK, Anton-Culver H, Antonenkova N, Antoniou AC, Armasu SM, , , Bacot F, Baglietto L, Bandera EV, Barnholtz-Sloan J, Beckmann MW, Birrer MJ, Bloom G, Bogdanova N, Brinton LA, Brooks-Wilson A, Brown R, Butzow R, Cai Q, Campbell I, Chang-Claude J, Chanock S, Chenevix-Trench G, Cheng JQ, Cicek MS, Coetzee GA, , Cook LS, Couch FJ, Cramer DW, Cunningham JM, Dansonka-Mieszkowska A, Despierre E, Doherty JA, Dörk T, du Bois A, Dürst M, Easton DF, Eccles D, Edwards R, Ekici AB, Fasching PA, Fenstermacher DA, Flanagan JM, Garcia-Closas M, Gentry-Maharaj A, Giles GG, Glasspool RM, Gonzalez-Bosquet J, Goodman MT, Gore M, Górski B, Gronwald J, Hall P, Halle MK, Harter P, Heitz F, Hillemanns P, Hoatlin M, Høgdall CK, Høgdall E, Hosono S, Jakubowska A, Jensen A, Jim H, Kalli KR, Karlan BY, Kaye SB, Kelemen LE, Kiemeney LA, Kikkawa F, Konecny GE, Krakstad C, Krüger Kjaer S, Kupryjanczyk J, Lambrechts D, Lambrechts S, Lancaster JM, Le ND, Leminen A, Levine DA, Liang D, Kiong Lim B, Lin J, Lissowska J, Lu KH, Lubiński J, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson SH, Orlow I, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Poole EM, Raska P, Renner SP, Risch HA, Rodriguez-Rodriguez L, Anne Rossing M, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schwaab I, Severi G, Shridhar V, Shu XO, Shvetsov YB, Sieh W, Song H, Southey MC, Spiewankiewicz B, Stram D, Sutphen R, Teo SH, Terry KL, Tessier DC, Thompson PJ, Tworoger SS, van Altena AM, Vergote I, Vierkant RA, Vincent D, Vitonis AF, Wang-Gohrke S, Palmieri Weber R, Wentzensen N, Whittemore AS, Wik E, Wilkens LR, Winterhoff B, Ling Woo Y, Wu AH, Xiang YB, Yang HP, Zheng W, Ziogas A, Zulkifli F, Phelan CM, Iversen E, Schildkraut JM, Berchuck A, Fridley BL, Goode EL, Pharoah PD, Monteiro AN, Sellers TA, Gayther SA.Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.Nat Commun. 2013 Mar 27;4:1627.
    23535648
  • Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, Bacot F, Vincent D, Cunningham JM, Dennis J, Dicks E, , , Aben KK, Anton-Culver H, Antonenkova N, Armasu SM, Baglietto L, Bandera EV, Beckmann MW, Birrer MJ, Bloom G, Bogdanova N, Brenton JD, Brinton LA, Brooks-Wilson A, Brown R, Butzow R, Campbell I, Carney ME, Carvalho RS, Chang-Claude J, Chen YA, Chen Z, Chow WH, Cicek MS, Coetzee G, Cook LS, Cramer DW, Cybulski C, Dansonka-Mieszkowska A, Despierre E, Doherty JA, Dörk T, du Bois A, Dürst M, Eccles D, Edwards R, Ekici AB, Fasching PA, Fenstermacher D, Flanagan J, Gao YT, Garcia-Closas M, Gentry-Maharaj A, Giles G, Gjyshi A, Gore M, Gronwald J, Guo Q, Halle MK, Harter P, Hein A, Heitz F, Hillemanns P, Hoatlin M, Høgdall E, Høgdall CK, Hosono S, Jakubowska A, Jensen A, Kalli KR, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Konecny GE, Krakstad C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee N, Lee J, Leminen A, Lim BK, Lissowska J, Lubiński J, Lundvall L, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson S, Orlow I, Paul J, Pejovic T, Pelttari LM, Permuth-Wey J, Pike MC, Poole EM, Qu X, Risch HA, Rodriguez-Rodriguez L, Rossing MA, Rudolph A, Runnebaum I, Rzepecka IK, Salvesen HB, Schwaab I, Severi G, Shen H, Shridhar V, Shu XO, Sieh W, Southey MC, Spellman P, Tajima K, Teo SH, Terry KL, Thompson PJ, Timorek A, Tworoger SS, van Altena AM, van den Berg D, Vergote I, Vierkant RA, Vitonis AF, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wik E, Winterhoff B, Woo YL, Wu AH, Yang HP, Zheng W, Ziogas A, Zulkifli F, Goodman MT, Hall P, Easton DF, Pearce CL, Berchuck A, Chenevix-Trench G, Iversen E, Monteiro AN, Gayther SA, Schildkraut JM, Sellers TA.GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.Nat Genet. 2013 Apr;45(4):362-70.
    23535730
  • Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, , , Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM, .Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.Endocr. Relat. Cancer. 2013;20(2):251-262.
    23404857
  • White KL, Vierkant RA, Fogarty Z, Charbonneau B, Block MS, Pharoah PD, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce L, Schildkraut JM, Menon U, Kruger Kjær S, Levine DA, Gronwald J, Anton-Culver H, Whittemore AS, Karlan BY, Lambrechts D, Wentzensen N, Kupryjanczyk J, Chang-Claude J, Bandera EV, Hogdall EV, Heitz F, Kaye S, Fasching PA, Campbell IG, Goodman MT, Pejovic T, Bean YT, Lurie G, Eccles D, Hein A, Beckmann MW, Ekici AB, Paul J, Brown R, Flanagan JM, Harter P, du Bois A, Schwaab I, Hogdall CK, Lundvall L, Olson SH, Orlow I, Paddock LE, Rudolph A, Eilber U, Dansonka-Mieszkowska A, Rzepecka IK, Ziolkowska-Seta I, Brinton LA, Yang HP, Garcia-Closas M, Despierre E, Lambrechts S, Vergote I, Walsh C, Lester J, Sieh W, McGuire V, Rothstein JH, Ziogas A, Lubinski J, Cybulski C, Menkiszak J, Jensen A, Gayther SA, Ramus SJ, Gentry-Maharaj A, Berchuck A, Wu AH, Pike MC, Van Den Berg D, Terry KL, Vitonis AF, Doherty JA, Johnatty SE, Defazio A, Song H, Tyrer J, Sellers TA, Phelan CM, Kalli KR, Cunningham JM, Fridley BL, Goode EL.Analysis of Over 10,000 Cases Finds No Association between Previously-Reported Candidate Polymorphisms and Ovarian Cancer Outcome.Cancer Epidemiol Biomarkers Prev. 2013 Mar 19.
    23513043
  • Kotsopoulos J, Terry KL, Poole EM, Rosner B, Murphy MA, Hecht JL, Crum CP, Missmer SA, Cramer DW, Tworoger SS.Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.Int J Cancer. 2013 Jan 30.
    23364849
  • Poole EM, Merritt MA, Jordan SJ, Yang HP, Hankinson SE, Park Y, Rosner B, Webb PM, Cramer DW, Wentzensen N, Terry KL, Tworoger SS.Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):429-37.
    23307531
  • Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, Ness RB, Kjaer SK, Chang-Claude J, Köbel M, Lurie G, Thompson PJ, Carney ME, Moysich K, Edwards R, Bunker C, Jensen A, Høgdall E, Cramer DW, Vitonis AF, Olson SH, King M, Chandran U, Lissowska J, Garcia-Closas M, Yang H, Webb PM, Schildkraut JM, Goodman MT, Risch HA, , .Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.BMC Cancer. 2013;13:28.
    23339562
  • Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, Fridley BL, Gayther SA, Goode EL, Iversen ES, Lissowska J, Weber RT, Pharoah PD, Phelan CM, Ramus SJ, Schildkraut JM, Sutphen R, Tsai YY, Tyrer J, Vierkant RA, Wentzensen N, Yang HP, Terry KL, Tworoger SS.ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.Cancer Causes Control. 2012 Nov;23(11):1805-10.
    22961099
  • Harris HR, Vivo ID, Titus LJ, Vitonis AF, Wong JY, Cramer DW, Terry KL.Genetic variation in telomere maintenance genes in relation to ovarian cancer survival.Int J Mol Epidemiol Genet. 2012;3(3):252-61.
    23050056
  • Benedict MD, Missmer SA, Ferguson KK, Vitonis AF, Cramer DW, Meeker JD.Secondhand tobacco smoke exposure is associated with prolactin but not thyroid stimulating hormone among nonsmoking women seeking in vitro fertilization.Environ. Toxicol. Pharmacol. 2012 Sep 23.
    23046534
  • Merritt MA, Kotsopoulos J, Cramer DW, Hankinson SE, Terry KL, Tworoger SS.Duarte galactose-1-phosphate uridyl transferase genotypes are not associated with ovarian cancer risk.Fertil Steril. 2012 Sep;98(3):687-91.
    22749219
  • Merritt MA, Cramer DW, Vitonis AF, Titus LJ, Terry KL.Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes.Int J Cancer. 2012 Jun 28.
    22740148
  • Cramer DW, Finn OJ.Epidemiologic perspective on immune-surveillance in cancer.Curr Opin Immunol. 2011 Apr;23(2):265-71.
    21277761
  • Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD, .A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer.Cancer Prev Res (Phila Pa). 2011 Mar;4(3):375-383.
    21372037
  • Cramer DW, Bast RC, Berg CD, Diamandis EP, Godwin AK, Hartge P, Lokshin AE, Lu KH, McIntosh MW, Mor G, Patriotis C, Pinsky PF, Thornquist MD, Scholler N, Skates SJ, Sluss PM, Srivastava S, Ward DC, Zhang Z, Zhu CS, Urban N.Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.Cancer Prev Res (Phila Pa). 2011 Mar;4(3):365-74.
    21372036
  • Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM, , , Kjær SK, Hogdall E, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Schildkraut JM, Moorman PG, Palmieri RT, Ness RB, Moysich K, Cramer DW, Terry KL, Vitonis AF, Pike MC, Berchuck A, Pearce CL, .Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.Fertil Steril. 2011 Jan;95(1):40-5.
    20719308
  • Cramer DW, O'Rourke DJ, Vitonis AF, Matulonis UA, Dijohnson DA, Sluss PM, Crum CP, Liu BC.CA125 Immune Complexes in Ovarian Cancer Patients with Typical CA125 Concentrations.Clin Chem. 2010 Dec;56(12):1889-92.
    20943848
  • Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS.ABO blood group and incidence of epithelial ovarian cancer.Int J Cancer. 2011 Jan 15;128(2):482-6.
    20309936
  • Cramer DW, Vitonis AF, Welch WR, Terry KL, Goodman A, Rueda BR, Berkowitz RS.Correlates of the preoperative level of CA125 at presentation of ovarian cancer.Gynecol Oncol. 2010 Dec;119(3):462-8.
    20850174
  • Terry KL, Tworoger SS, Goode EL, Gates MA, Titus-Ernstoff L, Kelemen LE, Sellers TA, Hankinson SE, Cramer DW.MTHFR polymorphisms in relation to ovarian cancer risk.Gynecol Oncol. 2010 Nov;119(2):319-24.
    20817226
  • Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman MT, Dörk T, Nevanlinna H, Ness RB, Rafnar T, Hogdall C, Hogdall E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, van Altena AM, Aben KK, Massuger LF, Brooks-Wilson A, Kelemen LE, Le ND, Jakubowska A, Lubinski J, Medrek K, Stafford A, Easton DF, Tyrer J, Bolton KL, Harrington P, Eccles D, Chen A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch HA, McLaughlin J, Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC, , Beesley J, Webb PM, , , , Chen X, Ekici AB, Thiel FC, Beckmann MW, Yang H, Wentzensen N, Lissowska J, Fasching PA, Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, Dürst M, Antonenkova N, Bogdanova N, Leminen A, Butzow R, Heikkinen T, Stefansson K, Sulem P, Besenbacher S, Sellers TA, Gayther SA, Pharoah PD, .A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.Nat Genet. 2010 Oct;42(10):874-9.
    20852632
  • Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Le ND, Cook LS, Kelemen LE, Brook-Wilson A, Massuger LF, Kiemeney LA, Aben KK, van Altena AM, Houlston R, Tomlinson I, Palmieri RT, Moorman PG, Schildkraut J, Iversen ES, Phelan C, Vierkant RA, Cunningham JM, Goode EL, Fridley BL, Kruger-Kjaer S, Blaeker J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Butzow R, Nevanlinna H, Leminen A, Bogdanova N, Antonenkova N, Doerk T, Hillemanns P, Dürst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen C, Rafnar T, Besenbacher S, Sulem P, Stefansson K, Birrer MJ, Terry KL, Hernandez D, Cramer DW, Vergote I, Amant F, Lambrechts D, Despierre E, Fasching PA, Beckmann MW, Thiel FC, Ekici AB, Chen X, , , , Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas M, Sellers T, Easton DF, Berchuck A, Chenevix-Trench G, Pharoah PD, Gayther SA.Common variants at 19p13 are associated with susceptibility to ovarian cancer.Nat Genet. 2010 Oct;42(10):880-4.
    20852633
  • Lurie G, Terry KL, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Palmieri RT, Cramer DW, Goodman MT.Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk.Cancer Causes Control. 2010 Oct;21(10):1731-41.
    20559705
  • Cramer DW, Vitonis AF, Pinheiro SP, McKolanis JR, Fichorova RN, Brown KE, Hatchette TF, Finn OJ.Mumps and ovarian cancer: modern interpretation of an historic association.Cancer Causes Control. 2010 Aug;21(8):1193-201.
    20559706
  • Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude J, Wang-Gohrke S, Cramer DW, Terry KL, Hankinson SE, Tworoger SS, Garcia-Closas M, Yang H, Lissowska J, Chanock SJ, Pharoah PD, Song H, Whitemore AS, Pearce CL, Stram DO, Wu AH, Pike MC, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Anton-Culver H, Ziogas A, Hogdall E, Kjaer SK, Hogdall C, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Phelan CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G, , , .Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".PLoS Genet. 2010;6(7):e1001016.
    20628624
  • Zhang L, Wang D, Jiang W, Edwards D, Qiu W, Barroilhet LM, Rho JH, Jin L, Seethappan V, Vitonis A, Wang J, Mok SC, Crum C, Cramer DW, Ye B.Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.Reprod. Biol. Endocrinol. 2010;8:74.
    20576130
  • Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM, , Köbel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G, , Cramer DW, Cunningham JM, Dicioccio RA, Doherty JA, Easton DF, Fredericksen ZS, Fridley BL, Gates MA, Gayther SA, Gentry-Maharaj A, Høgdall E, Kjaer SK, Lurie G, Menon U, Moorman PG, Moysich K, Ness RB, Palmieri RT, Pearce CL, Pharoah PD, Ramus SJ, Song H, Stram DO, Tworoger SS, Van Den Berg D, Vierkant RA, Wang-Gohrke S, Whittemore AS, Wilkens LR, Wu AH, Schildkraut JM, Sellers TA, Goode EL, .Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1822-30.
    20570913
  • Pinheiro SP, Hankinson SE, Tworoger SS, Rosner BA, McKolanis JR, Finn OJ, Cramer DW.Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies.Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1595-601.
    20501761
  • Anderson KS, Wong J, Vitonis A, Crum CP, Sluss PM, Labaer J, Cramer D.p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):859-68.
    20200435
  • Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, Wang-Gohrke S, Hein R, Green AC, Lissowska J, Carney ME, Lurie G, Wilkens LR, Ness RB, Pearce CL, Wu AH, Van Den Berg DJ, Stram DO, Terry KL, Whiteman DC, Whittemore AS, DiCioccio RA, McGuire V, Doherty JA, Rossing MA, Anton-Culver H, Ziogas A, Hogdall C, Hogdall E, Krüger Kjaer S, Blaakaer J, Quaye L, Ramus SJ, Jacobs I, Song H, Pharoah PD, Iversen ES, Marks JR, Pike MC, Gayther SA, Cunningham JM, Goodman MT, Schildkraut JM, Chenevix-Trench G, Berchuck A, Sellers TA, , .Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):600-4.
    20142253
  • Titus-Ernstoff L, Rees JR, Terry KL, Cramer DW.Breast-feeding the last born child and risk of ovarian cancer.Cancer Causes Control. 2010 Feb;21(2):201-7.
    19902367
  • Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Berchuck A, Moorman PG, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Yang HP, Garcia-Closas M, Chanock S, Lissowska J, Song H, Pharoah PD, Shah M, Perkins B, McGuire V, Whittemore AS, Di Cioccio RA, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Ziogas A, Brewster W, Anton-Culver H, , , Pearce CL, .ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):245-50.
    20056644
  • Terry KL, Tworoger SS, Gates MA, Cramer DW, Hankinson SE.Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.Carcinogenesis. 2009 Dec;30(12):2042-6.
    19858071
  • Tang L, Yang J, Ng SK, Rodriguez N, Choi PW, Vitonis A, Wang K, McLachlan GJ, Caiazzo RJ, Liu BC, Welch WR, Cramer DW, Berkowitz RS, Ng SW.Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.Eur J Cancer. 2010 Jan;46(1):170-9.
    19926475
  • Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, Baglietto L, Beckmann MW, Beesley J, Blaakaer J, Carney ME, Chanock S, Chen Z, Cunningham JM, Dicks E, Doherty JA, Dürst M, Ekici AB, Fenstermacher D, Fridley BL, Giles G, Gore ME, De Vivo I, Hillemanns P, Hogdall C, Hogdall E, Iversen ES, Jacobs IJ, Jakubowska A, Li D, Lissowska J, Lubiński J, Lurie G, McGuire V, McLaughlin J, Medrek K, Moorman PG, Moysich K, Narod S, Phelan C, Pye C, Risch H, Runnebaum IB, Severi G, Southey M, Stram DO, Thiel FC, Terry KL, Tsai YY, Tworoger SS, Van Den Berg DJ, Vierkant RA, Wang-Gohrke S, Webb PM, Wilkens LR, Wu AH, Yang H, Brewster W, Ziogas A, , , , Houlston R, Tomlinson I, Whittemore AS, Rossing MA, Ponder BA, Pearce CL, Ness RB, Menon U, Kjaer SK, Gronwald J, Garcia-Closas M, Fasching PA, Easton DF, Chenevix-Trench G, Berchuck A, Pharoah PD, Gayther SA.A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.Nat Genet. 2009 Sep;41(9):996-1000.
    19648919
  • Alper O, Stetler-Stevenson WG, Harris LN, Leitner WW, Ozdemirli M, Hartmann D, Raffeld M, Abu-Asab M, Byers S, Zhuang Z, Oldfield EH, Tong Y, Bergmann-Leitner E, Criss WE, Nagasaki K, Mok SC, Cramer DW, Karaveli FS, Goldbach-Mansky R, Leo P, Stromberg K, Weil RJ.Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma.Cancer Sci. 2009 Sep;100(9):1748-56.
    19594548
  • Pinheiro SP,Tworoger SS,Cramer DW,Rosner BA,Hankinson SE.Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.Am J Epidemiol. 2009 Jun 1;169(11):1378-87.
    19342401
  • Schildkraut JM,Goode EL,Clyde MA,Iversen ES,Moorman PG,Berchuck A,Marks JR,Lissowska J,Brinton L,Peplonska B,Cunningham JM,Vierkant RA,Rider DN,Chenevix-Trench G,Webb PM,Beesley J,Chen X,Phelan C,Sutphen R,Sellers TA,Pearce L,Wu AH,Van Den Berg D,Conti D,Elund CK,Anderson R,Goodman MT,Lurie G,Carney ME,Thompson PJ,Gayther SA,Ramus SJ,Jacobs I,Kruger Kjaer S,Hogdall E,Blaakaer J,Hogdall C,Easton DF,Song H,Pharoah PD,Whittemore AS,McGuire V,Quaye L,Anton-Culver H,Ziogas A,Terry KL,Cramer DW,Hankinson SE,Tworoger SS,Calingaert B,Chanock S,Sherman M,Garcia-Closas M.Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.Cancer Res. 2009 Mar 15;69(6):2349-57.
    19276375
  • Tworoger SS,Gate MA,Lee IM,Buring JE,Titus-Ernstoff L,Cramer D,Hankinson SE.Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.Cancer Res. 2009 Mar 1;69(5):1885-91.
    19223536
  • Gates MA,Vitonis AF,Tworoger SS,Rosner B,Titus-Ernstoff L,Hankinson SE,Cramer DW.Flavonoid intake and ovarian cancer risk in a population-based case-control study.Int J Cancer. 2009 Apr 15;124(8):1918-25.
    19117058
  • Gates MA,Tworoger SS,Terry KL,De Vivo I,Hunter DJ,Hankinson SE,Cramer DW.Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.Int J Cancer. 2009 Feb 1;124(3):729-33.
    18973230
  • Kotsopoulos J,Vitonis AF,Terry KL,De Vivo I,Cramer DW,Hankinson SE,Tworoger SS.Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.Cancer Causes Control. 2009 Apr;20(3):335-44.
    18941913
  • Gates MA,Tworoger SS,Terry KL,Titus-Ernstoff L,Rosner B,De Vivo I,Cramer DW,Hankinson SE.Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2436-44.
    18768514
  • Aponte M,Jiang W,Lakkis M,Li MJ,Edwards D,Albitar L,Vitonis A,Mok SC,Cramer DW,Ye B.Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.Cancer Res. 2008 Jul 15;68(14):5839-48.
    18632638
  • Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, Pharoah PD, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Terry KL, Cramer DW, Tworoger SS, Hankinson SE, Berchuck A, Moorman PG, Schildkraut JM, Cunningham JM, Liebow M, Kjaer SK, Hogdall E, Hogdall C, Blaakaer J, Ness RB, Moysich KB, Edwards RP, Carney ME, Lurie G, Goodman MT, Wang-Gohrke S, Kropp S, Chang-Claude J, Webb PM, Chen X, Beesley J, Chenevix-Trench G, Goode EL.Consortium analysis of 7 candidate SNPs for ovarian cancer.Int J Cancer. 2008 Jul 15;123(2):380-8.
    18431743
  • Ehrlich JR, Tang L, Caiazzo RJ Jr, Cramer DW, Ng SK, Ng SW, Liu BC.The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigens.Methods Mol Biol. 2008;441:175-92.
    18370319
  • Rasku MA, Clem AL, Telang S, Taft B, Gettings K, Gragg H, Cramer D, Lear SC, McMasters KM, Miller DM, Chesney J.Transient T cell depletion causes regression of melanoma metastases.J Transl Med. 2008;6:12.
    18334033
  • Anderson KS, Ramachandran N, Wong J, Raphael JV, Hainsworth E, Demirkan G, Cramer D, Aronzon D, Hodi FS, Harris L, Logvinenko T, LaBaer J.Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.J Proteome Res. 2008 Apr;7(4):1490-9.
    18311903
  • Pearce CL, Wu AH, Gayther SA, Bale AE, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, Hartmann LC, Hogdall E, Kjaer SK, Lissowska J, McGuire V, Modugno F, Moysich K, Ness RB, Ramus SJ, Risch HA, Sellers TA, Song H, Stram DO, Terry KL, Webb PM, Whiteman DC, Whittemore AS, Zheng W, Pharoah PD, Chenevix-Trench G, Pike MC, Schildkraut J, Berchuck A.Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.Br J Cancer. 2008 Jan 29;98(2):282-8.
    18219286
  • Reca R, Cramer D, Yan J, Laughlin MJ, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ.A novel role of complement in mobilization: immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complement-activating immunoglobulins.Stem Cells. 2007 Dec;25(12):3093-100.
    17717064
  • Li B, Allendorf DJ, Hansen R, Marroquin J, Cramer DE, Harris CL, Yan J.Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.Cancer Res. 2007 Aug 1;67(15):7421-30.
    17671212
  • Cramer DW, Welch WR, Berkowitz RS, Godleski JJ.Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc.Obstet Gynecol. 2007 Aug;110(2 Pt 2):498-501.
    17666642
  • Abenhaim HA, Titus-Ernstoff L, Cramer DW.Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider.CMAJ. 2007 Mar 27;176(7):941-7.
    17389442
  • Skates SJ, Horick NK, Moy JM, Minihan AM, Seiden MV, Marks JR, Sluss P, Cramer DW.Pooling of case specimens to create standard serum sets for screening cancer biomarkers.Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):334-41.
    17301268
  • Terry KL, Titus-Ernstoff L, McKolanis JR, Welch WR, Finn OJ, Cramer DW.Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):30-5.
    17220329
  • Pinheiro SP, Cramer DW.Non-genomic biomarkers of risk in ovarian cancer.Dis Markers.;23:355-66.
  • Ye B, Aponte M, Dai Y, Li L, Ho MC, Vitonis A, Edwards D, Huang TN, Cramer DW.Ginkgo biloba and ovarian cancer prevention: Epidemiological and biological evidence.Cancer Lett. 2007 Jun 18;251(1):43-52.
    17194528
  • Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP.A candidate precursor to serous carcinoma that originates in the distal fallopian tube.J Pathol. 2007 Jan;211(1):26-35.
    17117391
  • Meeker JD, Missmer SA, Cramer DW, Hauser R.Maternal exposure to second-hand tobacco smoke and pregnancy outcome among couples undergoing assisted reproduction.Hum Reprod. 2007 Feb;22(2):337-45.
    17053002
  • Morris SN, Missmer SA, Cramer DW, Powers RD, McShane PM, Hornstein MD.Effects of lifetime exercise on the outcome of in vitro fertilization.Obstet Gynecol. 2006 Oct;108(4):938-45.
    17012457
  • Tung JY, Rosen MP, Nelson LM, Turek PJ, Witte JS, Cramer DW, Cedars MI, Reijo Pera RA.Novel missense mutations of the Deleted-in-AZoospermia-Like (DAZL) gene in infertile women and men.Reprod Biol Endocrinol. 2006 Aug 2;4(1):40.
    16884537
  • Li B, Allendorf DJ, Hansen R, Marroquin J, Ding C, Cramer DE, Yan J.Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway.J Immunol. 2006 Aug 1;177(3):1661-9.
    16849475
  • Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP.The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.Am J Surg Pathol. 2006 Feb;30(2):230-6.
    16434898
  • Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, Edwards D, Sluss P, Han WK, Berkowitz RS, Cramer DW.Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.Clin Cancer Res. 2006 Jan 15;12(2):432-41.
    16428483
  • Tung JY, Rosen MP, Nelson LM, Turek PJ, Witte JS, Cramer DW, Cedars MI, Pera RA.Variants in Deleted in AZoospermia-Like (DAZL) are correlated with reproductive parameters in men and women.Hum Genet. 2006 Feb;118(6):730-740.
    16328470
  • Muscat J, Huncharek M, Cramer DW.Talc and anti-MUC1 antibodies.Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2679; author reply 2680.
    16284398
  • Terry KL, De Vivo I, Titus-Ernstoff L, Shih MC, Cramer DW.Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.Cancer Res. 2005 Jul 1;65(13):5974-81.
    15994977
  • Cramer DW, Titus-Ernstoff L, McKolanis JR, Welch WR, Vitonis AF, Berkowitz RS, Finn OJ.Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1125-31.
    15894662
  • Bendikson K, Cramer DW, Vitonis A, Hornstein MD.Ethnic background and in vitro fertilization outcomes.Int J Gynaecol Obstet. 2005 Mar;88(3):342-6.
    15733901
  • Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW.Genetic variation in the progesterone receptor gene and ovarian cancer risk.Am J Epidemiol. 2005 Mar 1;161(5):442-51.
    15718480
  • Terry KL, Sluss PM, Skates SJ, Mok SC, Ye B, Vitonis AF, Cramer DW.Blood and urine markers for ovarian cancer: a comprehensive review.Dis Markers. 2004;20(2):53-70.
    15322314
  • Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC.Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.Clin Cancer Res. 2004 May 15;10(10):3474-8.
    15161704
  • Fairfield KM, Hunter DJ, Colditz GA, Fuchs CS, Cramer DW, Speizer FE, Willett WC, Hankinson SE.A prospective study of dietary lactose and ovarian cancer.Int J Cancer. 2004 Jun 10;110(2):271-7.
    15069693
  • Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC.Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.Clin Cancer Res. 2003 Oct 15;9(13):4782-91.
    14581349
  • Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK, Licklider LJ, Schorge JO, Berkowitz RS, Mok SC.Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.Clin Cancer Res. 2003 Aug 1;9(8):2904-11.
    12912935
  • Terry KL, Titus-Ernstoff L, Garner EO, Vitonis AF, Cramer DW.Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk.Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):187-90.
    12646505
  • Goodman MT, Wu AH, Tung KH, McDuffie K, Cramer DW, Wilkens LR, Terada K, Reichardt JK, Ng WG.Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer.Am J Epidemiol. 2002 Oct 15;156(8):693-701.
    12370157
  • Kuper H, Cramer DW, Titus-Ernstoff L.Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status?.Cancer Causes Control. 2002 Jun;13(5):455-63.
    12146850
  • O'Regan A, Fleming C, Seidman JD, Wallach RC, Mok SC, Skates SJ, Berkowitz RS, Cramer DW.Osteopontin as a biomarker for ovarian cancer.JAMA. 2002 Jun 26;287:3208-3210.
  • Garner EI, Stokes EE, Berkowitz RS, Mok SC, Cramer DW.Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.Cancer Res. 2002 Jun 1;62(11):3058-62.
    12036914
  • Kim JH, Skates SJ, Uede T, Wong Kk KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC.Osteopontin as a potential diagnostic biomarker for ovarian cancer.JAMA. 2002 Apr 3;287(13):1671-9.
    11926891
  • Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R, Wu AH.Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.Am J Epidemiol. 2002 Feb 1;155(3):217-24.
    11821246
  • Cramer DW, Barbieri RL, Fraer AR, Harlow BL.Determinants of early follicular phase gonadotrophin and estradiol concentrations in women of late reproductive age.Hum Reprod. 2002 Jan;17(1):221-7.
    11756392
  • Cramer DW, Kuper H, Harlow BL, Titus-Ernstoff L.Carotenoids, antioxidants and ovarian cancer risk in pre- and postmenopausal women.Int J Cancer. 2001 Oct 1;94(1):128-34.
    11668487
  • Lucero J, Harlow BL, Barbieri RL, Sluss P, Cramer DW.Early follicular phase hormone levels in relation to patterns of alcohol, tobacco, and coffee use.Fertil Steril. 2001 Oct;76(4):723-9.
    11591405
  • Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW.Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.J Natl Cancer Inst. 2001 Oct 3;93(19):1458-64.
    11584061
  • Cramer DW, Petterson KS, Barbieri RL, Huhtaniemi IT.Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone.Hum Reprod. 2000 Oct;15(10):2103-7.
    11006181
  • Kuper H, Titus-Ernstoff L, Harlow BL, Cramer DW.Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer.Int J Cancer. 2000 Oct 15;88(2):313-8.
    11004686
  • Whiteman DC, Murphy MF, Cook LS, Cramer DW, Hartge P, Marchbanks PA, Nasca PC, Ness RB, Purdie DM, Risch HA.Multiple births and risk of epithelial ovarian cancer.J Natl Cancer Inst. 2000 Jul 19;92(14):1172-7.
    10904091
  • Lu KH, Garber JE, Cramer DW, Welch WR, Niloff J, Schrag D, Berkowitz RS, Muto MG.Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.J Clin Oncol. 2000 Jul;18(14):2728-32.
    10894872
  • Marchbanks PA, Wilson H, Bastos E, Cramer DW, Schildkraut JM, Peterson HB.Cigarette smoking and epithelial ovarian cancer by histologic type.Obstet Gynecol. 2000 Feb;95(2):255-60.
    10674590
  • Cramer DW, Greenberg ER, Titus-Ernstoff L, Liberman RF, Welch WR, Li E, Ng WG.A case-control study of galactose consumption and metabolism in relation to ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):95-101.
    10667469
  • Gertig DM, Hunter DJ, Cramer DW, Colditz GA, Speizer FE, Willett WC, Hankinson SE.Prospective study of talc use and ovarian cancer.J Natl Cancer Inst. 2000 Feb 2;92(3):249-52.
    10655442
  • Cramer DW, Liberman RF, Titus-Ernstoff L, Welch WR, Greenberg ER, Baron JA, Harlow BL.Genital talc exposure and risk of ovarian cancer.Int J Cancer. 1999 May 5;81(3):351-6.
    10209948
  • Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS.Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.Epidemiology. 1998 Sep;9(5):570-3.
    9730040
  • Cramer DW, Liberman RF, Hornstein MD, McShane P, Powers D, Li EY, Barbieri R.Basal hormone levels in women who use acetaminophen for menstrual pain.Fertil Steril. 1998 Aug;70(2):371-3.
    9696240
  • Cramer DW, Harlow BL, Titus-Ernstoff L, Bohlke K, Welch WR, Greenberg ER.Over-the-counter analgesics and risk of ovarian cancer.Lancet. 1998 Jan 10;351(9096):104-7.
    9439495
  • Cramer DW, Xu H.Predicting age at menopause.Maturitas. 1996 Apr;23(3):319-26.
    8794427
  • Cramer DW, Goldstein DP, Fraer C, Reichardt JK.Vaginal agenesis (Mayer-Rokitansky-Kuster-Hauser syndrome) associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT).Mol Hum Reprod. 1996 Mar;2(3):145-8.
    9238673
  • Cramer DW, Hornstein MD, Ng WG, Barbieri RL.Endometriosis associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT).Mol Hum Reprod. 1996 Mar;2(3):149-52.
    9238674
  • Cramer DW, Harlow BL, Xu H, Fraer C, Barbieri R.Cross-sectional and case-controlled analyses of the association between smoking and early menopause.Maturitas. 1995 Sep;22(2):79-87.
    8538488
  • Cramer DW, Xu H.Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer.Ann Epidemiol. 1995 Jul;5(4):310-4.
    8520714
  • Harlow BL, Cramer DW.Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-control studies (Massachusetts, United States).Cancer Causes Control. 1995 Mar;6(2):130-4.
    7749052
  • Cramer DW, Xu H, Harlow BL.Does "incessant" ovulation increase risk for early menopause?.Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):568-73.
    7856687
  • Harlow BL, Frigoletto FD, Cramer DW, Evans JK, Bain RP, Ewigman B, McNellis D.Epidemiologic predictors of cesarean section in nulliparous patients at low risk. RADIUS Study Group. Routine Antenatal Diagnostic Imaging with Ultrasound Study.Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):156-62.
    7847528
  • Cramer DW, Barbieri RL, Xu H, Reichardt JK.Determinants of basal follicle-stimulating hormone levels in premenopausal women.J Clin Endocrinol Metab. 1994 Oct;79(4):1105-9.
    7962282
  • Cramer DW, Barbieri RL, Muto MG, Kelly A, Brucks JP, Harlow BL.Characteristics of women with a family history of ovarian cancer. II. Follicular phase hormone levels.Cancer. 1994 Aug 15;74(4):1318-22.
    8055454
  • Cramer DW, Xu H, Sahi T.Adult hypolactasia, milk consumption, and age-specific fertility.Am J Epidemiol. 1994 Feb 1;139(3):282-9.
    8116603
  • Cramer DW, Harlow BL.Commentary: re: "A case-control study of milk drinking and ovarian cancer risk".Am J Epidemiol. 1991 Sep 1;134(5):454-6.
    1897500
  • Cramer DW.Lactase persistence and milk consumption as determinants of ovarian cancer risk.Am J Epidemiol. 1989 Nov;130(5):904-10.
    2510499
  • Cramer DW, Harlow BL, Willett WC, Welch WR, Bell DA, Scully RE, Ng WG, Knapp RC.Galactose consumption and metabolism in relation to the risk of ovarian cancer.Lancet. 1989 Jul 8;2(8654):66-71.
    2567871
  • Cramer DW, Harlow BL, Barbieri RL, Ng WG.Galactose-1-phosphate uridyl transferase activity associated with age at menopause and reproductive history.Fertil Steril. 1989 Apr;51(4):609-15.
    2538369
  • Cramer DW, Ravnikar VA, Craighill M, Ng WG, Goldstein DP, Reilly R.Mllerian aplasia associated with maternal deficiency of galactose-1-phosphate uridyl transferase.Fertil Steril. 1987 Jun;47(6):930-4.
    3036608
  • Cramer DW, Goldman MB, Schiff I, Belisle S, Albrecht B, Stadel B, Gibson M, Wilson E, Stillman R, Thompson I.The relationship of tubal infertility to barrier method and oral contraceptive use.JAMA. 1987 May 8;257(18):2446-50.
    3573242
  • Cramer DW, Wilson E, Stillman RJ, Berger MJ, Belisle S, Schiff I, Albrecht B, Gibson M, Stadel BV, Schoenbaum SC.The relation of endometriosis to menstrual characteristics, smoking, and exercise.JAMA. 1986 Apr 11;255(14):1904-8.
    3951117
  • Cramer DW, Schiff I, Schoenbaum SC, Gibson M, Belisle S, Albrecht B, Stillman RJ, Berger MJ, Wilson E, Stadel BV.Tubal infertility and the intrauterine device.N Engl J Med. 1985 Apr 11;312(15):941-7.
    3974684
  • Cramer DW, Welch WR, Hutchison GB, Willett W, Scully RE.Dietary animal fat in relation to ovarian cancer risk.Obstet Gynecol. 1984 Jun;63(6):833-8.
    6728366
  • Cramer DW, Welch WR.Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis.J Natl Cancer Inst. 1983 Oct;71(4):717-21.
    6578367
  • Cramer DW, Welch WR, Cassells S, Scully RE.Mumps, menarche, menopause, and ovarian cancer.Am J Obstet Gynecol. 1983 Sep 1;147(1):1-6.
    6614075
  • Cramer DW, Hutchison GB, Welch WR, Scully RE, Knapp RC.Factors affecting the association of oral contraceptives and ovarian cancer.N Engl J Med. 1982 Oct 21;307(17):1047-51.
    7121514
  • Cramer DW, Welch WR, Scully RE, Wojciechowski CA.Ovarian cancer and talc: a case-control study.Cancer. 1982 Jul 15;50(2):372-6.
    7083145
  • Cramer DW, Devesa SS, Welch WR.Trends in the incidence of endometrioid and clear cell cancers of the ovary in the United States.Am J Epidemiol. 1981 Aug;114(2):201-8.
    7304555